Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $802.4600 (6.83%) ($802.4600 - $802.4600) on Thu. Mar. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.93% (three month average) | RSI | 55 | Latest Price | $802.4600(6.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.4% a day on average for past five trading days. | Weekly Trend | REGN advances 0.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(43%) DIA(33%) VYM(30%) IWD(28%) | Factors Impacting REGN price | REGN will decline at least -0.965% in a week (0% probabilities). VXX(-24%) VIXM(-15%) UUP(-2%) TBT(-2%) ARKK(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.965% (StdDev 1.93%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $763.88(5.05%) | 10 Day Moving Average | $760.01(5.59%) | 20 Day Moving Average | $761.72(5.35%) | To recent high | 0% | To recent low | 17.9% | Market Cap | $85.084b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |